193 related articles for article (PubMed ID: 22635525)
21. Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.
Kong Y; Yao H; Ren H; Subbian S; Cirillo SL; Sacchettini JC; Rao J; Cirillo JD
Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12239-44. PubMed ID: 20566877
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.
Chopra S; Matsuyama K; Tran T; Malerich JP; Wan B; Franzblau SG; Lun S; Guo H; Maiga MC; Bishai WR; Madrid PB
J Antimicrob Chemother; 2012 Feb; 67(2):415-21. PubMed ID: 22052686
[TBL] [Abstract][Full Text] [Related]
23. Novel Assay Platform to Evaluate Intracellular Killing of
Horváti K; Fodor K; Pályi B; Henczkó J; Balka G; Gyulai G; Kiss É; Biri-Kovács B; Senoner Z; Bősze S
Front Immunol; 2021; 12():750496. PubMed ID: 34867981
[TBL] [Abstract][Full Text] [Related]
24. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
[TBL] [Abstract][Full Text] [Related]
25. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
[TBL] [Abstract][Full Text] [Related]
26. Isoniazid and Rifapentine Treatment Eradicates Persistent
Foreman TW; Bucşan AN; Mehra S; Peloquin C; Doyle LA; Russell-Lodrigue K; Gandhi NR; Altman J; Day CL; Ernst JD; Blumberg HM; Rengarajan J; Kaushal D
Am J Respir Crit Care Med; 2020 Feb; 201(4):469-477. PubMed ID: 31647877
[No Abstract] [Full Text] [Related]
27. Rapid molecular detection of tuberculosis and rifampin resistance.
Boehme CC; Nabeta P; Hillemann D; Nicol MP; Shenai S; Krapp F; Allen J; Tahirli R; Blakemore R; Rustomjee R; Milovic A; Jones M; O'Brien SM; Persing DH; Ruesch-Gerdes S; Gotuzzo E; Rodrigues C; Alland D; Perkins MD
N Engl J Med; 2010 Sep; 363(11):1005-15. PubMed ID: 20825313
[TBL] [Abstract][Full Text] [Related]
28. Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
Magotra A; Sharma A; Singh S; Ojha PK; Kumar S; Bokolia N; Wazir P; Sharma S; Khan IA; Singh PP; Vishwakarma RA; Singh G; Nandi U
Pulm Pharmacol Ther; 2018 Feb; 48():151-160. PubMed ID: 29174840
[TBL] [Abstract][Full Text] [Related]
29. Rapid determination of growth inhibition of Mycobacterium tuberculosis by GC-MS/MS quantitation of tuberculostearic acid.
Cai G; Pauli GF; Wang Y; Jaki BU; Franzblau SG
Tuberculosis (Edinb); 2013 May; 93(3):322-9. PubMed ID: 23454100
[TBL] [Abstract][Full Text] [Related]
30. Formulation studies of InhA inhibitors and combination therapy to improve efficacy against Mycobacterium tuberculosis.
Knudson SE; Cummings JE; Bommineni GR; Pan P; Tonge PJ; Slayden RA
Tuberculosis (Edinb); 2016 Dec; 101():8-14. PubMed ID: 27865404
[TBL] [Abstract][Full Text] [Related]
31. Intravital excitation increases detection sensitivity for pulmonary tuberculosis by whole-body imaging with β-lactamase reporter enzyme fluorescence.
Nooshabadi F; Yang HJ; Cheng Y; Durkee MS; Xie H; Rao J; Cirillo JD; Maitland KC
J Biophotonics; 2017 Jun; 10(6-7):821-829. PubMed ID: 27753271
[TBL] [Abstract][Full Text] [Related]
32. Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum.
Jain P; Weinrick BC; Kalivoda EJ; Yang H; Munsamy V; Vilcheze C; Weisbrod TR; Larsen MH; O'Donnell MR; Pym A; Jacobs WR
mBio; 2016 Oct; 7(5):. PubMed ID: 27795387
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterium tuberculosis Reporter Strains as Tools for Drug Discovery and Development.
Abramovitch RB
IUBMB Life; 2018 Sep; 70(9):818-825. PubMed ID: 29707888
[TBL] [Abstract][Full Text] [Related]
34. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
35. Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!
Srivastava S; Deshpande D; Magombedze G; Gumbo T
Clin Infect Dis; 2018 Nov; 67(suppl_3):S359-S364. PubMed ID: 30496465
[TBL] [Abstract][Full Text] [Related]
36. Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.
De Groote MA; Gruppo V; Woolhiser LK; Orme IM; Gilliland JC; Lenaerts AJ
Antimicrob Agents Chemother; 2012 Feb; 56(2):731-8. PubMed ID: 22143517
[TBL] [Abstract][Full Text] [Related]
37. Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis.
Sharma A; Vaghasiya K; Ray E; Gupta P; Kumar Singh A; Datta Gupta U; Kumar Verma R
Int J Pharm; 2019 Mar; 558():231-241. PubMed ID: 30630076
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis.
Xu Y; Wang L; Zimmerman MD; Chen KY; Huang L; Fu DJ; Kaya F; Rakhilin N; Nazarova EV; Bu P; Dartois V; Russell DG; Shen X
PLoS Pathog; 2018 Apr; 14(4):e1006974. PubMed ID: 29698476
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.
Vicente E; Villar R; Burguete A; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
Antimicrob Agents Chemother; 2008 Sep; 52(9):3321-6. PubMed ID: 18625764
[TBL] [Abstract][Full Text] [Related]
40. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
Dutta NK; Mazumdar K; Dastidar SG; Park JH
Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
